IMR Press / EJGO / Volume 18 / Issue 5 / pii/1997154

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Case Report

Prolonged remission of platinum-refractory ovarian cancer with docetaxel: brief report and review of literature

Show Less
1 The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA
Eur. J. Gynaecol. Oncol. 1997, 18(5), 341–342;
Published: 10 October 1997
Abstract

Platinum-based chemotherapy is the standard treatment for ovarian cancer, with response rates of 70-80%. Docetaxel has an increasing role as salvage therapy in patients with platinum-refractory ovarian cancer. In this report, we present the case of a patient with platinum-refractory ovarian cancer who achieved a long-term complete remission with docetaxel therapy. Two years after com­pletion of chemotherapy with docetaxel, she continues to have no evidence of disease.

Keywords
Ovarian cancer
Docetaxel
Prolonged complete remission
Share
Back to top